tiprankstipranks
Inhibrx (INBX)
NASDAQ:INBX

Inhibrx (INBX) Income Statement

66 Followers

Inhibrx Income Statement

Last quarter (Q4 2023), Inhibrx's total revenue was $1.63M, an increase of 496.35% from the same quarter last year. In Q4, Inhibrx's net income was $-93.60M. See Inhibrx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.80M$ 1.80M$ 2.19M$ 7.23M$ 12.81M$ 13.21M
Cost of Revenue
------
Gross Profit
$ 1.80M$ 1.80M$ 2.19M$ 7.23M--
Operating Expense
$ 221.02M$ 221.02M$ 131.31M$ -83.80M$ 80.25M$ 56.92M
Operating Income
$ -219.22M$ -219.22M$ -129.12M$ -76.56M$ -67.44M$ -43.71M
Net Non Operating Interest Income Expense
--$ -16.11M$ -5.22M$ -10.82M$ -5.72M
Other Income Expense
$ 22.14M$ 22.14M$ -1.00K$ -14.00K$ 2.63M$ -1.07M
Pretax Income
$ -239.72M$ -239.72M$ -145.22M$ -81.77M$ -75.63M$ -50.50M
Tax Provision
$ 3.00K$ 3.00K$ 3.00K$ 2.00K$ 3.00K$ 898.00K
Earnings From Equity Interest Net Of Tax
$ -1.63M$ -1.63M--$ -487.00K$ 0.00
Net Income Common Stockholders
$ -241.36M$ -241.36M$ -145.23M$ -81.77M$ -76.12M$ -51.40M
Basic EPS
$ -5.03$ -5.12$ -3.62$ -2.15$ -3.01$ -1.67
Diluted EPS
$ -5.03$ -5.12$ -3.62$ -2.15$ -3.01$ -1.67
Basic Average Shares
$ 188.52M$ 47.13M$ 40.11M$ 38.01M$ 25.26M$ 27.08M
Diluted Average Shares
$ 188.52M$ 47.13M$ 40.11M$ 38.01M$ 25.26M$ 27.08M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 41.17M$ 221.02M$ 131.31M$ -83.80M$ 80.25M$ 56.92M
Net Income From Continuing And Discontinued Operation
$ -241.36M$ -241.36M$ -145.23M$ -81.77M$ -76.12M$ -51.40M
Normalized Income
$ -78.08M---$ -78.04M$ -50.66M
Interest Expense
----$ 10.82M$ 5.72M
EBIT
$ -142.67M$ -239.72M$ -145.22M$ -76.55M$ -64.82M$ -44.78M
EBITDA
$ -87.88M$ -233.63M$ -140.55M$ -74.12M$ -63.80M$ -43.62M
Currency in USD

Inhibrx Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis